PAVmed Inc. Quarterly Cost of Revenue in USD from Q3 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
PAVmed Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2021 to Q3 2024.
- PAVmed Inc. Cost of Revenue for the quarter ending September 30, 2024 was $1.38M, a 22.4% decline year-over-year.
- PAVmed Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $6.4M, a 0.44% decline year-over-year.
- PAVmed Inc. annual Cost of Revenue for 2023 was $6.42M, a 77.6% increase from 2022.
- PAVmed Inc. annual Cost of Revenue for 2022 was $3.61M, a 518% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)